Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Therapeutic Hypothermia Systems Market, by Application
1.4.2 North America Therapeutic Hypothermia Systems Market, by Product
1.4.3 North America Therapeutic Hypothermia Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Strategies Deployed in the Therapeutic Hypothermia Systems Market
4.3 Porter’s Five Forces Analysis
Chapter 5. North America Therapeutic Hypothermia Systems Market, by Application
5.1 North America Neurology Market, by Country
5.2 North America Cardiology Market, by Country
5.3 North America Neonatal Care Market, by Country
5.4 North America Others Market, by Country
Chapter 6. North America Therapeutic Hypothermia Systems Market, by Product
6.1 North America Cooling Devices Market, by Country
6.2 North America Cooling Catheters Market, by Country
6.3 North America Cool Caps Market, by Country
Chapter 7. North America Therapeutic Hypothermia Systems Market, by Country
7.1 US Therapeutic Hypothermia Systems Market
7.1.1 US Therapeutic Hypothermia Systems Market, by Application
7.1.2 US Therapeutic Hypothermia Systems Market, by Product
7.2 Canada Therapeutic Hypothermia Systems Market
7.2.1 Canada Therapeutic Hypothermia Systems Market, by Application
7.2.2 Canada Therapeutic Hypothermia Systems Market, by Product
7.3 Mexico Therapeutic Hypothermia Systems Market
7.3.1 Mexico Therapeutic Hypothermia Systems Market, by Application
7.3.2 Mexico Therapeutic Hypothermia Systems Market, by Product
7.4 Rest of North America Therapeutic Hypothermia Systems Market
7.4.1 Rest of North America Therapeutic Hypothermia Systems Market, by Application
7.4.2 Rest of North America Therapeutic Hypothermia Systems Market, by Product
Chapter 8. Company Profiles
8.1 Asahi Kasei Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson, and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Gentherm Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Stryker Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Belmont Medical Technologies (Audax Management Company, LLC.)
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 EM-MED Sp. z o.o. Sp. K.
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 International Biomedical Ltd.
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Phoenix Medical Systems Pvt. Ltd.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Shenzhen Comen Medical Instruments Co., Ltd.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Terumo Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Product Launches and Product Expansions:
8.10.5.2 Acquisition and Mergers:
8.10.6 SWOT Analysis
Chapter 9. Winning Imperatives of Therapeutic Hypothermia Systems Market
Unique Offerings 